ReviewInternational journal of oncology2022

Treatment of patients with cancer using PD‑1/PD‑L1 antibodies: Adverse effects and management strategies (Review).

Guangshun Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.